Jordens J Z, Bates J, Griffiths D T
Public Health Laboratory, University of Oxford, John Radcliffe Hospital, Headington, UK.
J Antimicrob Chemother. 1994 Oct;34(4):515-28. doi: 10.1093/jac/34.4.515.
Eight clinical isolates of vancomycin-resistant Enterococcus faecium (VRE) were obtained from four renal and four other in-patients within an 11 week period during 1992. Characterisation of the isolates by restriction enzyme analysis with Sal I and rRNA gene restriction patterns (ribotyping) showed them to be clonally related. During the next 3 months an additional 14 VRE were isolated from hospital patients, nine of which were indistinguishable by ribotyping from the strain associated with the outbreak. An epidemiological survey was instigated in order to determine the level of carriage of this VRE. A total of 354 stool specimens was screened using a highly selective enrichment broth. VRE were detected in the stools of 11/73 (15%) of renal patients, 5/97 (5%) of other hospital patients and 3/184 (2%) of patients based in the community. Of the 25 stool isolates that were further characterised by ribotyping, 17 were indistinguishable from the outbreak strain. The remaining eight isolates gave seven different patterns. Patients harbouring the outbreak strain stayed in hospital significantly longer and had received more antibiotic treatment, for longer, than those patients from whom other VRE had been isolated. There was no significant difference in vancomycin or cephalosporin usage between the two groups of patients. Ribotyping showed there to be a number of clones of VRE carried by patients and that one of these clones was especially prevalent and has been responsible for the outbreak of infection in the renal unit. The technique also showed the presence of different VRE in general practice patients suggesting they are not just a hospital phenomenon.
1992年的11周内,从4名肾病患者和4名其他住院患者中分离出8株耐万古霉素屎肠球菌(VRE)临床分离株。通过用Sal I进行限制性酶切分析和rRNA基因限制性图谱(核糖分型)对分离株进行鉴定,结果显示它们具有克隆相关性。在接下来的3个月里,又从医院患者中分离出14株VRE,其中9株通过核糖分型与此次暴发相关的菌株无法区分。于是开展了一项流行病学调查,以确定这种VRE的携带水平。使用高度选择性增菌肉汤对总共354份粪便标本进行了筛查。在肾病患者的粪便中检测到VRE的比例为11/73(15%),其他医院患者为5/97(5%),社区患者为3/184(2%)。在通过核糖分型进一步鉴定的25株粪便分离株中,17株与暴发菌株无法区分。其余8株分离株呈现出7种不同的图谱。携带暴发菌株的患者住院时间明显更长,接受抗生素治疗的时间也更长,且使用剂量更大,这一点与分离出其他VRE的患者相比有显著差异。两组患者在万古霉素或头孢菌素的使用上没有显著差异。核糖分型显示患者携带多种VRE克隆,其中一种克隆特别普遍,并且是肾病病房感染暴发的原因。该技术还显示在全科患者中存在不同的VRE,这表明它们不仅仅是医院内的现象。